Role of NADPH-oxidases and uncoupled endothelial NO-synthase in pulmonary arterial hypertension induced by chronic hypoxia

被引：0
|
作者：
Delannoy, E.
Leblais, V.
Courtois, A.
Gadeau, A. P.
Desgranges, C.
Closs, E.
Li, H.
Marthan, R.
Muller, B.
机构：
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2009年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
260
引用
收藏
页码：52 / 52
页数：1
相关论文
共 50 条
  • [21] Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension
    Santos-Gomes, Joana
    Le Ribeuz, Helene
    Bras-Silva, Carmen
    Antigny, Fabrice
    Adao, Rui
    BIOMOLECULES, 2022, 12 (04)
  • [22] Role of the NADPH Oxidases in the Subfornical Organ in Angiotensin II-Induced Hypertension
    Lob, Heinrich E.
    Schultz, David
    Marvar, Paul J.
    Davisson, Robin L.
    Harrison, David G.
    HYPERTENSION, 2013, 61 (02) : 382 - +
  • [23] Iptakalim attenuates hypoxia-induced pulmonary arterial hypertension in rats by endothelial function protection
    Zhu, Rong
    Bi, Li-Qing
    Wu, Su-Ling
    Li, Lan
    Kong, Hui
    Xie, Wei-Ping
    Wang, Hong
    Meng, Zi-Li
    MOLECULAR MEDICINE REPORTS, 2015, 12 (02) : 2945 - 2952
  • [24] Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition
    Yu, Min
    Peng, Liyao
    Liu, Ping
    Yang, Mingxia
    Zhou, Hong
    Ding, Yirui
    Wang, Jingjing
    Huang, Wen
    Tan, Qi
    Wang, Yanli
    Xie, Weiping
    Kong, Hui
    Wang, Hong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 1191 - 1202
  • [25] PTEN Depletion in Pulmonary Arteries Does Not Augment Chronic Hypoxia-Induced Pulmonary Arterial Pulmonary Hypertension
    Waypa, G. B.
    Smith, K. A.
    Dudley, V. J.
    Schumacker, P. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [26] Endothelial Fibroblast Growth Factor Receptor 1 Promotes Chronic Hypoxia Induced Pulmonary Arterial Hypertension Involving Estrogen Receptors
    Racanelli, A.
    Chavez, D.
    Guo, P.
    Ding, B.
    Choi, A. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [27] NADPH oxidase 4 is not involved in hypoxia-induced pulmonary hypertension
    Veith, C.
    Kraut, S.
    Wilhelm, J.
    Sommer, N.
    Quanz, K.
    Seeger, W.
    Brandes, R. P.
    Weissmann, N.
    Schroeder, K.
    PULMONARY CIRCULATION, 2016, 6 (03) : 397 - 400
  • [28] Selective upregulation of arterial endothelial nitric oxide synthase in pulmonary hypertension
    Resta, TC
    Gonzales, RJ
    Dail, WG
    Sanders, TC
    Walker, BR
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 272 (02): : H806 - H813
  • [29] Gene polymorphisms of endothelial nitric oxide synthase in pulmonary arterial hypertension
    Jansa, P.
    Jachymova, M.
    Sladkova, H.
    Skvarilova, M.
    Palecek, T.
    Kovarik, A.
    Linhart, A.
    Aschermann, M.
    EUROPEAN HEART JOURNAL, 2005, 26 : 82 - 82
  • [30] Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension
    Chen, Feng
    Li, Xueyi
    Aquadro, Emily
    Haigh, Stephen
    Zhou, Jiliang
    Stepp, David W.
    Weintraub, Neal L.
    Barman, Scott A.
    Fulton, David J. R.
    FREE RADICAL BIOLOGY AND MEDICINE, 2016, 99 : 167 - 178
12345